Bi-Weekly Newsletter 1-14-2022
Our 2021 in numbers | How Probiotics are Being Used to Combat COVID-19 | The In (vitro, vivo, silico)s and Outs of Research | More…
Our 2021 in numbers | How Probiotics are Being Used to Combat COVID-19 | The In (vitro, vivo, silico)s and Outs of Research | More…
New product Announcement | Gene Mutations Involved in Epilepsy and Cortical Hyperexcitability | More…
Before we put 2020 in the rearview mirror, let’s take a look at everything we were able to accomplish!
End of year sale is on now | Zebrafish genome editing: CRISPR vs. Tol2 | Dr. Judith Eisen on 17 Minutes of Science | More…
Get rid of these pesky proteins | Identify a successful transgenic edit in C. elegans | An Inside Look at Our Zebrafish Husbandry | More…
Be prepared, just in case | The benefits of using C. elegans in toxicology studies | Neurodegenerative disease models | more….
How to Design a Good Phenotype Based Drug Discovery Program | Functional Analysis of Variants Using C. elegans | more….
Zebrafish Modeling of COVID-19 Susceptibility in Rare Disease | C. elegans CV | Increasing Diversity in STEM | more….
In the News | Genetic models for COVID-19 Research | A Scientist’s Journey From the Lab Bench to Policy-Making | more….
In the News | Genetic models for COVID-19 Research | A Scientist’s Journey From the Lab Bench to Policy-Making | more….